Remedium Lifecare Ltd has reported Standalone financial results for the period ended June 30, 2023.
Financial Results (Q1 FY2024) - QoQ Comparison
The company has reported total income of Rs. 330.4648 crores during the period ended June 30, 2023 as compared to Rs. 75.5796 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs. 5.2463 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -4.7813 crores for the period ended March 31, 2023.
The company has reported EPS of Rs. 14.57 for the period ended June 30, 2023 as compared to Rs. -13.28 for the period ended March 31, 2023.
Total Income | ₹ 330.4648 crs | ₹75.5796 crs | 337.24% |
Net Profit | ₹5.2463 crs | ₹-4.7813 crs | 209.73% |
EPS | ₹14.57 | ₹-13.28 | 209.71% |
Financial Results (Q1 FY2024) - YoY Comparison The company has reported total income of Rs. 330.4648 crores during the period ended June 30, 2023 as compared to Rs.99.3274 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs.5.2463 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.6.4961 crores for the period ended June 30, 2022.
The company has reported EPS of Rs.14.57 for the period ended June 30, 2023 as compared to Rs.18.04 for the period ended June 30, 2022.
Total Income | ₹ 330.4648 crs | ₹99.3274 crs | 232.70% |
Net Profit | ₹5.2463 crs | ₹6.4961 crs | -19.24% |
EPS | ₹14.57 | ₹18.04 | -19.24% |
Shares of Remedium Lifecare Ltd was last trading in BSE at Rs. 1635.30 as compared to the previous close of Rs. 1662.20. The total number of shares traded during the day was 12527 in over 579 trades.
The stock hit an intraday high of Rs. 1665.00 and intraday low of 1620.00. The net turnover during the day was Rs. 20451271.00.
Source : Equity Bulls
Keywords
RemediumLifecare
Q1FY24
ResultUpdate